Literature DB >> 32059783

Lymphoma Driver Mutations in the Pathogenic Evolution of an Iconic Human Autoantibody.

Mandeep Singh1, Katherine J L Jackson1, Jing J Wang2, Peter Schofield3, Matt A Field4, David Koppstein5, Timothy J Peters1, Deborah L Burnett3, Simone Rizzetto5, Damien Nevoltris3, Etienne Masle-Farquhar3, Megan L Faulks1, Amanda Russell1, Divya Gokal1, Asami Hanioka6, Keisuke Horikawa7, Alexander D Colella8, Timothy K Chataway9, James Blackburn3, Tim R Mercer10, David B Langley1, D Margaret Goodall11, Roy Jefferis11, Muralikrishna Gangadharan Komala12, Anthony D Kelleher5, Dan Suan13, Maureen Rischmueller14, Daniel Christ3, Robert Brink3, Fabio Luciani15, Tom P Gordon2, Christopher C Goodnow16, Joanne H Reed17.   

Abstract

Pathogenic autoantibodies arise in many autoimmune diseases, but it is not understood how the cells making them evade immune checkpoints. Here, single-cell multi-omics analysis demonstrates a shared mechanism with lymphoid malignancy in the formation of public rheumatoid factor autoantibodies responsible for mixed cryoglobulinemic vasculitis. By combining single-cell DNA and RNA sequencing with serum antibody peptide sequencing and antibody synthesis, rare circulating B lymphocytes making pathogenic autoantibodies were found to comprise clonal trees accumulating mutations. Lymphoma driver mutations in genes regulating B cell proliferation and V(D)J mutation (CARD11, TNFAIP3, CCND3, ID3, BTG2, and KLHL6) were present in rogue B cells producing the pathogenic autoantibody. Antibody V(D)J mutations conferred pathogenicity by causing the antigen-bound autoantibodies to undergo phase transition to insoluble aggregates at lower temperatures. These results reveal a pre-neoplastic stage in human lymphomagenesis and a cascade of somatic mutations leading to an iconic pathogenic autoantibody.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  autoantibody; cryoglobulinemia; lymphoma; rheumatoid factor; single cell omics; somatic mutation; vasculitis

Year:  2020        PMID: 32059783     DOI: 10.1016/j.cell.2020.01.029

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  26 in total

1.  TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate.

Authors:  Leandro Venturutti; Matt Teater; Andrew Zhai; Amy Chadburn; Leena Babiker; Daleum Kim; Wendy Béguelin; Tak C Lee; Youngjun Kim; Christopher R Chin; William T Yewdell; Brian Raught; Jude M Phillip; Yanwen Jiang; Louis M Staudt; Michael R Green; Jayanta Chaudhuri; Olivier Elemento; Pedro Farinha; Andrew P Weng; Michael D Nissen; Christian Steidl; Ryan D Morin; David W Scott; Gilbert G Privé; Ari M Melnick
Journal:  Cell       Date:  2020-07-02       Impact factor: 41.582

2.  Distinction of lymphoid and myeloid clonal hematopoiesis.

Authors:  Abhishek Niroula; Aswin Sekar; Mark A Murakami; Mark Trinder; Mridul Agrawal; Waihay J Wong; Alexander G Bick; Md Mesbah Uddin; Christopher J Gibson; Gabriel K Griffin; Michael C Honigberg; Seyedeh M Zekavat; Kaavya Paruchuri; Pradeep Natarajan; Benjamin L Ebert
Journal:  Nat Med       Date:  2021-10-18       Impact factor: 53.440

3.  Human T-bet governs the generation of a distinct subset of CD11chighCD21low B cells.

Authors:  Rui Yang; Danielle T Avery; Katherine J L Jackson; Masato Ogishi; Ibtihal Benhsaien; Likun Du; Xiaofei Ye; Jing Han; Jérémie Rosain; Jessica N Peel; Marie-Alexandra Alyanakian; Bénédicte Neven; Sarah Winter; Anne Puel; Bertrand Boisson; Kathryn J Payne; Melanie Wong; Amanda J Russell; Yoko Mizoguchi; Satoshi Okada; Gulbu Uzel; Christopher C Goodnow; Sylvain Latour; Jalila El Bakkouri; Aziz Bousfiha; Kahn Preece; Paul E Gray; Baerbel Keller; Klaus Warnatz; Stéphanie Boisson-Dupuis; Laurent Abel; Qiang Pan-Hammarström; Jacinta Bustamante; Cindy S Ma; Jean-Laurent Casanova; Stuart G Tangye
Journal:  Sci Immunol       Date:  2022-07-22

4.  Diverse mutational landscapes in human lymphocytes.

Authors:  Emily Mitchell; Nina F Øbro; Kirsten Kübler; Heather E Machado; Megan Davies; Daniel Leongamornlert; Alyssa Cull; Francesco Maura; Mathijs A Sanders; Alex T J Cagan; Craig McDonald; Miriam Belmonte; Mairi S Shepherd; Felipe A Vieira Braga; Robert J Osborne; Krishnaa Mahbubani; Iñigo Martincorena; Elisa Laurenti; Anthony R Green; Gad Getz; Paz Polak; Kourosh Saeb-Parsy; Daniel J Hodson; David G Kent; Peter J Campbell
Journal:  Nature       Date:  2022-08-10       Impact factor: 69.504

Review 5.  Somatic mutations in rheumatological diseases: VEXAS syndrome and beyond.

Authors:  Keith A Sikora; Kristina V Wells; Ertugrul Cagri Bolek; Adrianna I Jones; Peter C Grayson
Journal:  Rheumatology (Oxford)       Date:  2022-08-03       Impact factor: 7.046

6.  The dangers of déjà vu: memory B cells as the cells of origin of ABC-DLBCLs.

Authors:  Leandro Venturutti; Ari M Melnick
Journal:  Blood       Date:  2020-11-12       Impact factor: 22.113

Review 7.  Use of checkpoint inhibitors in patients with lymphoid malignancies receiving allogeneic cell transplantation: a review.

Authors:  Sabela Bobillo; Juan Camilo Nieto; Pere Barba
Journal:  Bone Marrow Transplant       Date:  2021-03-19       Impact factor: 5.174

Review 8.  The Autoantigen Repertoire and the Microbial RNP World.

Authors:  Sandra G Williams; Sandra L Wolin
Journal:  Trends Mol Med       Date:  2021-03-12       Impact factor: 11.951

9.  Repertoire Analysis of B-Cells Located in Striated Ducts of Salivary Glands of Patients With Sjögren's Syndrome.

Authors:  Annie Visser; Gwenny M Verstappen; Bert van der Vegt; Arjan Vissink; Richard J Bende; Hendrika Bootsma; Nicolaas A Bos; Frans G M Kroese
Journal:  Front Immunol       Date:  2020-07-14       Impact factor: 7.561

Review 10.  Base Excision Repair in the Immune System: Small DNA Lesions With Big Consequences.

Authors:  Maria Stratigopoulou; Tijmen P van Dam; Jeroen E J Guikema
Journal:  Front Immunol       Date:  2020-05-29       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.